Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients

Calcineurin inhibitor–associated nephrotoxicity and other adverse events have prompted efforts to minimize/eliminate calcineurin inhibitor use in kidney transplant recipients. METHODS: This open-label, randomized, multinational study evaluated the effect of planned transition from tacrolimus to siro...

Descripción completa

Detalles Bibliográficos
Autores principales: Tedesco-Silva, Helio, Peddi, V. Ram, Sánchez-Fructuoso, Ana, Marder, Brad A., Russ, Graeme R., Diekmann, Fritz, Flynn, Alison, Hahn, Carolyn M., Li, Huihua, Tortorici, Michael A., Schulman, Seth L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946511/
https://www.ncbi.nlm.nih.gov/pubmed/27500260
http://dx.doi.org/10.1097/TXD.0000000000000579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946511/
https://www.ncbi.nlm.nih.gov/pubmed/27500260
http://dx.doi.org/10.1097/TXD.0000000000000579

Ejemplares similares